Edwards Lifesciences Corp
General ticker "EW" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $43.3B
Edwards Lifesciences Corp does not follow the US Stock Market performance with the rate: -11.8%.
Estimated limits based on current volatility of 1.1%: low 73.14$, high 74.75$
Factors to consider:
- Company included in S&P500 list
- US accounted for 58.4% of revenue in the fiscal year ended 2023-12-31
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [63.66$, 97.64$]
- 2024-12-30 to 2025-12-30 estimated range: [78.44$, 115.56$]
Financial Metrics affecting the EW estimates:
- Negative: Operating cash flow per share per price, % of 2.06 <= 2.35
- Positive: Operating profit margin, % of 25.55 > 19.51
- Positive: Non-GAAP EPS, $ of 2.51 > 2.29
- Positive: Return on assets ratio (scaled to [-100,100]) of 13.00 > 7.10
- Negative: Industry operating cash flow per share per price (median), % of -5.15 <= 3.85
- Negative: Industry operating profit margin (median), % of -26.46 <= 2.14
Short-term EW quotes
Long-term EW plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $5,232.50MM | $5,382.40MM | $6,004.80MM |
| Operating Expenses | $3,542.20MM | $3,633.90MM | $4,470.70MM |
| Operating Income | $1,690.30MM | $1,748.50MM | $1,534.10MM |
| Non-Operating Income | $11.70MM | $18.90MM | $64.00MM |
| Interest Expense | $18.40MM | $19.20MM | $17.60MM |
| R&D Expense | $903.10MM | $945.20MM | $1,071.80MM |
| Income(Loss) | $1,702.00MM | $1,767.40MM | $1,598.10MM |
| Taxes | $198.90MM | $245.50MM | $198.70MM |
| Profit(Loss) | $1,503.10MM | $1,521.90MM | $1,399.40MM |
| Stockholders Equity | $5,835.90MM | $5,806.70MM | $6,650.00MM |
| Inventory | $726.70MM | $875.50MM | $1,168.20MM |
| Assets | $8,502.60MM | $8,292.50MM | $9,363.20MM |
| Operating Cash Flow | $1,732.10MM | $1,218.20MM | $895.80MM |
| Capital expenditure | $329.80MM | $264.80MM | $266.30MM |
| Investing Cash Flow | $-1,722.50MM | $252.30MM | $173.80MM |
| Financing Cash Flow | $-356.30MM | $-1,584.50MM | $-711.00MM |
| Earnings Per Share* | $2.41 | $2.46 | $2.31 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.